Edition:
United Kingdom

Loxo Oncology Inc (LOXO.OQ)

LOXO.OQ on NASDAQ Stock Exchange Global Market

139.73USD
8:59pm GMT
Change (% chg)

$4.25 (+3.14%)
Prev Close
$135.48
Open
$138.88
Day's High
$141.65
Day's Low
$137.20
Volume
144,223
Avg. Vol
112,451
52-wk High
$208.78
52-wk Low
$78.08

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 42.47 -0.887
Jun '18 42.60 -0.389
Mar '18 38.43 -0.119
FY 2017 Dec '17 21.30 -0.688
Sep '17 0.00 -2.454
Jun '17 0.00 -1.143
Mar '17 0.00 -0.956
FY 2016 Dec '16 0.00 -1.260
Sep '16 0.00 -0.819
Jun '16 0.00 -0.773
Mar '16 0.00 -0.593
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 10 58.58 99.25 45.40 23.59
Quarter Ending Mar-19 5 50.48 75.40 30.70 13.62
Year Ending Dec-18 11 178.32 224.00 139.37 31.34
Year Ending Dec-19 9 174.39 396.90 15.60 97.47
Earnings (per share)
Quarter Ending Dec-18 11 -0.81 -0.04 -1.23 -0.84
Quarter Ending Mar-19 6 -0.70 -0.06 -1.71 -0.83
Year Ending Dec-18 10 -2.16 -1.43 -2.60 -5.04
Year Ending Dec-19 10 -3.26 3.20 -9.08 -4.42
LT Growth Rate (%) 1 37.00 37.00 37.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.72 34.40
P/E High - Last 5 Yrs. -- 148.04 46.21
P/E Low - Last 5 Yrs. -- 47.80 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) -- 49.54 6.22
Price to Book (MRQ) 5.67 10.17 5.20
Price to Tangible Book (MRQ) 5.67 13.82 6.74
Price to Cash Flow (TTM) -- 52.81 24.17
% Owned Institutions -- 3.75 1.77

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 129.94 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 47.86 6.50
Sales - 5 Yr. Growth Rate -- 22.77 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -47.91 75.89 23.27
EPS (TTM) vs TTM 1 Yr. Ago -60.01 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 42.15 3.43 3.10
LT Debt to Equity (MRQ) 0.00 18.73 11.49
Total Debt to Equity (MRQ) 0.00 31.43 16.03
Interest Coverage (TTM) -- -43.28 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.35 54.44
Gross Margin - 5 Yr. Avg. -- 60.59 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -109.93 13.16
Operating Margin (TTM) -- -184.87 6.07
Operating Margin - 5 Yr. Avg. -- -126.36 8.47
Pre-Tax Margin (TTM) -- -175.63 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.51 8.71
Net Profit Margin (TTM) -- -182.37 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.91 4.90
Effective Tax Rate (TTM) -- 21.48 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.58 23.84

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,652,294 873,073,486
Net Income/Employee (TTM) -3,441,862 652,908 103,486,338
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.00 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.82 6.46 11.45
Return on Assets - 5 Yr. Avg. -- 5.53 12.50
Return on Investment (TTM) -31.65 9.00 14.96
Return on Investment - 5 Yr. Avg. -- 6.86 16.23
Return on Equity (TTM) -31.65 10.14 16.53
Return on Equity - 5 Yr. Avg. -- 8.39 17.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -63.08 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Loxo Oncology Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 14.65 10.70 76 98
13 Week 14.21 8.65 69 94
26 Week 83.39 69.45 90 98
52 Week 280.96 222.90 97 68
YTD 172.96 139.71 93 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 99.41%
# of Holders: 326
Total Shares Held: 30,432,781
3 Mo. Net Change: -303,462
# New Positions: 42
# Closed Positions: 27
# Increased Positions: 166
# Reduced Positions: 122
# Net Buyers: 44
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.